About the Authors

Francois Peyron

Contributed equally to this work with: Francois Peyron, Jose G. Montoya

francois.peyron@chu-lyon.fr

Affiliation Hospices Civils de Lyon, Institut de Parasitologie et mycologie médicale, Hôpital de la Croix Rousse, Lyon, France

Rima Mc Leod

‡ RM and DA also contributed equally to this work. DCI and FK also contributed equally to this work. LM and LDS also contributed equally to this work. HP and IV also contributed equally to this work. MW also contributed equally to this work.

Affiliations Department of Ophthalmology and Visual Science, Department of Pediatrics (Infectious Diseases), The University of Chicago, Chicago, Illinois, United States of America, Toxoplasmosis Center, Institute for Genomics and Systems Biology, The University of Chicago, Chicago, Illinois, United States of America, Global Health Center, CHeSS, The University of Chicago, Chicago, Illinois, United States of America

Daniel Ajzenberg

‡ RM and DA also contributed equally to this work. DCI and FK also contributed equally to this work. LM and LDS also contributed equally to this work. HP and IV also contributed equally to this work. MW also contributed equally to this work.

Affiliations Centre National de Référence (CNR) Toxoplasmose / Toxoplasma Biological Resource Center (BRC), Centre Hospitalier-Universitaire Dupuytren, Limoges, France, INSERM UMR 1094, Neuroépidémiologie Tropicale, Laboratoire de Parasitologie-Mycologie, Faculté de Médecine, Université de Limoges, Limoges, France

Despina Contopoulos-Ioannidis

‡ RM and DA also contributed equally to this work. DCI and FK also contributed equally to this work. LM and LDS also contributed equally to this work. HP and IV also contributed equally to this work. MW also contributed equally to this work.

Affiliation Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, California, United States of America

François Kieffer

‡ RM and DA also contributed equally to this work. DCI and FK also contributed equally to this work. LM and LDS also contributed equally to this work. HP and IV also contributed equally to this work. MW also contributed equally to this work.

Affiliation Neonatal Intensive Care Unit, Armand Trousseau Hospital–Assistance Publique–Hopitaux de Paris, Paris, France

Laurent Mandelbrot

‡ RM and DA also contributed equally to this work. DCI and FK also contributed equally to this work. LM and LDS also contributed equally to this work. HP and IV also contributed equally to this work. MW also contributed equally to this work.

Affiliations Hopital Louis Mourier, Assistance Publique–Hopitaux de Paris, Colombes, France, Centre de Recherche en Epidémiologie et Sante des Populations, INSERM U1018, Le Kremlin-Bicêtre, France, Université Paris Diderot—Paris 7, Paris, France

L. David Sibley

‡ RM and DA also contributed equally to this work. DCI and FK also contributed equally to this work. LM and LDS also contributed equally to this work. HP and IV also contributed equally to this work. MW also contributed equally to this work.

Affiliation Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, United States of America

Hervé Pelloux

‡ RM and DA also contributed equally to this work. DCI and FK also contributed equally to this work. LM and LDS also contributed equally to this work. HP and IV also contributed equally to this work. MW also contributed equally to this work.

Affiliations Parasitologie-Mycologie Pole Biologie, CHU A. Michallon, Grenoble, France, UMR 5163 CNRS/Université Grenoble Alpes, Grenoble, France

Isabelle Villena

‡ RM and DA also contributed equally to this work. DCI and FK also contributed equally to this work. LM and LDS also contributed equally to this work. HP and IV also contributed equally to this work. MW also contributed equally to this work.

Affiliations Laboratoire de Parasitologie-Mycologie, Centre National de Référence de la Toxoplasmose, Centre de Ressources Biologiques Toxoplasma, Hôpital Maison Blanche Reims, France, EA 3800, SFR CAP-SANTE, Université Champagne-Ardenne, Reims, France

Martine Wallon

‡ RM and DA also contributed equally to this work. DCI and FK also contributed equally to this work. LM and LDS also contributed equally to this work. HP and IV also contributed equally to this work. MW also contributed equally to this work.

Affiliations Hospices Civils de Lyon, Institut de Parasitologie et mycologie médicale, Hôpital de la Croix Rousse, Lyon, France, Physiologie intégrée du système d'éveil Centre de recherche en neurosciences de Lyon, INSERM U1028-CNRS UMR 5292, Lyon, France

Jose G. Montoya

Contributed equally to this work with: Francois Peyron, Jose G. Montoya

Affiliations Department of Medicine and Division of Infectious Diseases, Stanford University School of Medicine, Stanford, California, United States of America, Palo Alto Medical Foundation Toxoplasma Serology Laboratory, Palo Alto, California, United States of America

Competing Interests

FP runs reference centers for toxoplasmic serology funded respectively by Abbott and Siemens companies. JGM is Director of Palo Alto Medical Foundation Toxoplasmosis Serology Laboratory.